Click 
to remove filters
The International Public Relations Association (IPRA) has named Manning, Selvage and Lee executive vice-president Alasdair Sutherland as its president for 2001. The current president is Roy Sanada of Japan, who will be succeeded by Carolyn Raffa Fazio, who chairs US sponsorship agency International.
The Medical Channel, the first daily medical TV channel for doctors, will launch in February 2000. It will be broadcast through Sky Digital from 7am to 10pm and will show news, current affairs, medical advances and further education programmes. The channel, founded by Jeremy Walsh, will target GPs,...
Company: Glaxo Wellcome Issue: National Institute of Clinical Excellence recommendation on Relenza At: www.glaxowellcome.co.uk
PR Week found itself going round in circles when following up the story that the National Institute of Clinical Excellence (NICE) wouldn t recommend Glaxo Wellcome s Relenza as an NHS drug.
Independent medical research body, the Wellcome Trust is looking for a PR heavyweight to head its communications and public affairs, with a brief to inform the public on issues such as cloning and animal organ transplants.
United News and Media, Britain s biggest media owner, has poached Channel 4 s corporate affairs head Sue Robertson to run communications at its broadcasting arm. United Broadcasting and Entertainment owns Meridian, Anglian and HTV, and a 29 per cent stake in Channel 5. Robertson will be responsible...
Two big brands of indigestion tablets, Rennie and Gaviscon, are slugging it out in a most ungentlemanly PR battle.
Letizia Moratti, chairman and chief executive of News Corporation Europe, resigned on Tuesday, after less than a year in the job. Internal differences have been given as the cause of her departure, with Moratti quoted as saying that her beliefs were 'not shared by News Corp'.
1961: Leaves school for secretarial position at IPC
Merck Sharp and Dohme, part of the world s largest pharmaceutical company, is expanding its use of corporate and public affairs agencies in response to new NHS legislation.
